Gufeng Xu, Ph.D. - Publications
Affiliations: | Hematology-Oncology | Texas Children’s Cancer Center |
Website:
http://txch.org/doctors/dr-ching-lau/Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Sun JM, Chow WY, Xu G, Hicks MJ, Nakka M, Shen J, Ng PKS, Taylor AM, Yu A, Farrar JE, Barkauskas DA, Gorlick R, Guidry Auvil JM, Gerhard D, Meltzer P, et al. The Role of FAS Receptor Methylation in Osteosarcoma Metastasis. International Journal of Molecular Sciences. 24. PMID 37569529 DOI: 10.3390/ijms241512155 | 0.441 | |||
2011 | Xu G, Wang H, Rainusso NC, Flores RJ, Triche T, Man T, Lau CC. Abstract 5331: CHK1 inhibition enhances chemosensitivity of p53 deficient osteosarcoma cells Cancer Research. 71: 5331-5331. DOI: 10.1158/1538-7445.Am2011-5331 | 0.496 | |||
2010 | Xu G, Shen J, Yu A, Wang H, Man TK, Lau CC. Abstract 3402: Knockdown of TWIST1 increases chemosensitivity of osteosarcoma cells Cancer Research. 70: 3402-3402. DOI: 10.1158/1538-7445.Am10-3402 | 0.501 | |||
Show low-probability matches. |